2FODOR JG, FROHLICH J J, JACQUES JG, et al. Recommen- dations for the management and treatment of dyslipidemia [J]. CMAJ, 2000,162:1441-7.
3GARBER AJ,KARLSSON FO. Treatment of dyslipidemia in diabetes. Endocrinol Metab Clin North Am[J]. 2001,30: 999-1010.
4ARONOW W. Cholesterol 2001:Rationale for lipid-lowering in older patients with or without CAD[J]. Geriatrics, 2001, 56:22-30.
5Prevention of cardiovascular events and deathwith pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Isehaemic Disease(LIPID) Study Group[J]. N Engl ] med, 1998,39 : 1349-1357.
6ECKEL R H. Approach to the patient who is intolerantof sta- tin therapy[J]. J Clin Endocrinol Metab, 2010, 95,95 (5) : 2015-2022.
7THOMPSON PD,CLARKSON P, KARAS RH. Statin-asso- ciated myopathy[J]. JAMA,2003 ;89:681-1690.
8GEMICI G,TOPRAK A,OKTAY A. Rhabdomyolysis due to cerivaitatin monotherapy[J]. Am J Med, 2001, 1109, 110 (9) :742.
1Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：346
5ROBINS S. Low high - density lipoprotein cholesterol and response to simvastatin therapy in Scandinavian Simvastatin Survival Study ( 4S ) [ J ] . Circulation, 2002, 106 (2): e8.
6SCHECHTER C B, BARZILAI N, CRANDALL J P, et al. Cholesteryl ester transfer protein (CETP) genotype and reduced CETP levels associated with decreased prevalence of hypertension[ Jl. Mayo Clin Proc, 2010, 85 (6) : 522-526.
7ECKEL R H. Approach to the patient who is intolerant of statin therapy[ J]. J Clin Endocrinol Metab, 2010, 95 (5): 2015-2022.
5Russo MW, Jacobson IM. How to use statins in patients with chronic liver disease? [ J]. Cleve Clin J Med,2004, 71 ( 1 ) :58-62.
6Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism [J].Am J Cardiovasc Drugs,2008,8(6) :373-418.
7Tavintharan S, Ong CN, Jeyaseelan K, et al. Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin- induced hepatotoxicity? [ J ]. Toxicol Appl Pharmacol, 2007,223 (2) :173-179.
9Komatsu T, Tachibana H, Sato Y, et al. Long-term efficacy of upstream therapy with lipophilic or hydrophilic statins on antiarrhythmin drugs in patients with paroxysmal atrial fibrillation[J]. Int Heart J,2011,52(6) :359-365.
